Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.

作者: Santiago Tofé , José C Moreno , Luis Máiz , Milagros Alonso , Héctor Escobar

DOI: 10.1530/EJE.1.01836

关键词:

摘要: Objective: To evaluate insulin-secretion kinetics and insulin sensitivity in cystic fibrosis (CF) patients with normal glucose tolerance (CF-NGT), impaired (CF-IGT) or CF-related diabetes (CFRD), the potential effects of moderate hyperglycemia on clinical nutritional status. Design methods: Cross-sectional study including 50 outpatients CF. Patients underwent both oral (OGGT) intravenous (IVGTT) tests order to assess secretion peripheral sensitivity. Homeostasis assessment model OGGT were used investigate Forced expiratory volume first second (FEV1) forced vital capacity (FVC) measured pulmonary function. Body mass index (BMI) was determined Results: Insulin significantly decreased (and delayed at OGTT) CFRD group (n ¼ 9) versus CF-IGT 10) CF-NGT 31). different groups group. FEV1, FVC BMI presented a significant linear correlation plasma value 120 min OGTT lower group, whereas no differences found between groups. Conclusions: CF IGT present diminished increased resistance, correlating worse status, undernutrition These findings open question whether early treatment mild alterations metabolism secretagogues short-action may lead improvement status patients.

参考文章(42)
Lanng S, Diabetes mellitus in cystic fibrosis. European Journal of Gastroenterology & Hepatology. ,vol. 8, pp. 744- 747 ,(1996)
P. M. O'Byrne, D. W. Cockcroft, E. F. Juniper, S. D. Anderson, J. L. Malo, P. H. Quanjer, Leonardo Fabbri, P. J. Sterk, Airway Responsiveness. Standardized Challenge Testing With Pharmacological, Physical and Sensitizing Stimuli in Adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society The European respiratory journal. Supplement. ,vol. 16, pp. 53- 83 ,(1993)
Dana S. Hardin, Adrian Leblanc, Gailen Marshall, Dan K. Seilheimer, Mechanisms of insulin resistance in cystic fibrosis American Journal of Physiology-endocrinology and Metabolism. ,vol. 281, ,(2001) , 10.1152/AJPENDO.2001.281.5.E1022
ANDREA BALLABIO, RICHARDA. GIBBS, C. THOMAS CASKEY, PCR test for cystic fibrosis deletion. Nature. ,vol. 343, pp. 220- 220 ,(1990) , 10.1038/343220A0
H. J. Neijens, M. Sinaasappel, R. de Groot, J. C. de Jongste, S. E. Overbeek, Cystic fibrosis, pathophysiological and clinical aspects. European Journal of Pediatrics. ,vol. 149, pp. 742- 751 ,(1990) , 10.1007/BF01957271
S Lanng, B Thorsteinsson, C Lund-Andersen, J Nerup, PO Schiøtz, C Koch, Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatrica. ,vol. 83, pp. 72- 77 ,(1994) , 10.1111/J.1651-2227.1994.TB12956.X
A. Moran, D. Hardin, D. Rodman, H.F. Allen, R.J. Beall, D. Borowitz, C. Brunzell, P.W. Campbell III, S.E. Chesrown, C. Duchow, R.J. Fink, S.C. Fitzsimmons, N. Hamilton, I. Hirsch, M.S. Howenstine, D.J. Klein, Z. Madhun, P.B. Pencharz, A.L. Quittner, M.K., Robbins, T. Schindler, K. Schissel, S.J. Schwarzenberg, V.A. Stallings, D.E. Tullis, W.B. Zipf, Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Research and Clinical Practice. ,vol. 45, pp. 61- 73 ,(1999) , 10.1016/S0168-8227(99)00058-3
H SAUERWEIN, A SCHOLS, Glucose metabolism in chronic lung disease Clinical Nutrition. ,vol. 21, pp. 367- 371 ,(2002) , 10.1054/CLNU.2002.0561
Stanley M. Finkelstein, Catherine L. Wielinski, Greg R. Elliott, Warren J. Warwick, Jose Barbosa, Shu-Chen Wu, David J. Klein, Diabetes mellitus associated with cystic fibrosis The Journal of Pediatrics. ,vol. 112, pp. 373- 377 ,(1988) , 10.1016/S0022-3476(88)80315-9
S Lanng, Glucose intolerance in cystic fibrosis patients Paediatric Respiratory Reviews. ,vol. 2, pp. 253- 259 ,(2001) , 10.1053/PRRV.2001.0148